Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
150.00
-1.27 (-0.84%)
Dec 5, 2025, 4:00 PM EST - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $5.23 billion as of December 5, 2025. Its market cap has increased by 105.84% in one year.
Market Cap
5.23B
Enterprise Value
4.96B
1-Year Change
105.84%
Ranking
Category
Stock Price
$150.00
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $5.23B, an increase of 3,520.10%. That is a compound annual growth rate of 170.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 5.23B | 168.60% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |